Paola Panetta
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia.
Journal: Annals of hematology
Published: May 11, 2025
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.
Journal: Frontiers in oncology
Published: February 08, 2022
Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration.
Journal: Hematology/oncology and stem cell therapy
Published: December 10, 2019
Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.
Journal: American journal of hematology
Published: February 05, 2018
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia.
Journal: Molecular and clinical oncology
Published: September 15, 2017
Identification of a potential topoisomerase II "hotspot" DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms.
Journal: Annals of hematology
Published: September 02, 2016
Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients.
Journal: Annals of hematology
Published: February 24, 2015
BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib.
Journal: Biochimica et biophysica acta
Published: July 21, 2014
Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia.
Journal: American journal of hematology
Published: July 10, 2014
Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromes.
Journal: The Journal of molecular diagnostics : JMD
Published: June 03, 2014
Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin.
Journal: British journal of haematology
Published: October 22, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026